217
Views
2
CrossRef citations to date
0
Altmetric
Review Articles

Sudden cardiac death in sports: could we save Pheidippides?

& ORCID Icon
Pages 945-959 | Received 29 Oct 2020, Accepted 16 Dec 2020, Published online: 08 Jan 2021

References

  • Mohananey D, Masri A, Desai R, et al. Global incidence of sports-related sudden cardiac death. J Am Coll Cardiol. 2017;69(21):2672–2679.
  • Finocchiaro G, Papadakis M, Robertus JL, et al. Etiology of sudden death in sports: insights from a United Kingdom Regional Registry. J Am Coll Cardiol. 2016;67(18):2108–2115.
  • Sharma S, Merghani A, Mont L. Exercise and the heart: the good, the bad, and the ugly . Eur Heart J. 2015;36(23):1445–1453.
  • Corrado D, Pelliccia A, Bjørnstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(5):516–524.
  • Borjesson M, Urhausen A, Kouidi E, et al. Cardiovascular evaluation of middle-aged/ senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2011;18(3):446–458.
  • Bolognesi M. Pre-participation screening of competitive of middle-aged athletes: certainties and doubts in daily practice. J Integr Cardiol. 2016;1(6):1000142.
  • Colivicchi F, Ammirati F, Biffi A, et al. Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome. Eur Heart J. 2002;23(14):1125–1130.
  • Maron BJ, Haas TS, Ahluwalia A, et al. Demographics and epidemiology of sudden deaths in young competitive athletes: from the United States National Registry. Am J Med. 2016;129(11):1170–1177.
  • Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2362–2371.
  • Marijon E, Uy-Evanado A, Reinier K, et al. Sudden cardiac arrest during sports activity in middle age. Circulation. 2015;131(16):1384–1391.
  • Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119(8):1085–1092.
  • Corrado D, Basso C, Rizzoli G, et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol. 2003;42(11):1959–1963.
  • Harmon K, Drezner J. Evolving etiology of sudden cardiac death in adolescent and young adult athletes. https://www.acc.org/latest-in-cardiology/articles/2018/03/05.
  • Harmon KG, Asif IM, Maleszewski JJ, et al. Incidence, cause, and comparative frequency of sudden cardiac death in National Collegiate Athletic Association Athletes: a decade in review. Circulation. 2015;132(1):10–19.
  • La Gerche A, Heidbuchel H. Can intensive exercise harm the heart? You can get too much of a good thing. Circulation. 2014;130(12):992–1002.
  • Shave R, Oxborough D. Exercise-induced cardiac injury: evidence from novel imaging techniques and highly sensitive cardiac troponin assays. Prog Cardiovasc Dis. 2012;54(5):407–415.
  • Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2002;40(3):446–452.
  • Heidbuchel H, Prior DL, La Gerche A. Ventricular arrhythmias associated with long-term endurance sports: what is the evidence? Br J Sports Med. 2012;46(Suppl 1):i44–i50.
  • Varró A, Baczkó I. Possible mechanisms of sudden cardiac death in top athletes: a basic cardiac electrophysiological point of view. Pflugers Arch. 2010;460(1):31–40.
  • Samie F, Jalife J. Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart. Cardiovasc Res. 2001;50(2):242–250.
  • de Groot SHM, Schoenmakers M, Molenschot MMC, et al. Contractile adaptations preserving cardiac output predispose the hypertrophied canine heart to delayed afterdepolarization-dependent ventricular arrhythmias. Circulation. 2000;102(17):2145–2151.
  • Jordaens LA. A clinical approach to arrhythmias revisited in 2018: from ECG over noninvasive and invasive electrophysiology to advanced imaging. Neth Heart J. 2018;26(4):182–189.
  • Vancini RL, Nikolaidis PT, Barbosa de Lira CA, et al. Prevention of sudden death related to sport: the science of basic life support—from theory to practice. J Clin Med. 2019; 8:556–569.
  • Link M. Commotio cordis: ventricular fibrillation triggered by chest impact–induced abnormalities in repolarization. Circ Arrhythmia Electrophysiol. 2012; 5:425–432.
  • Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296(13):1593–1601.
  • Deligiannis A, Anastasakis A, Antoniades L, et al. Recommendations for the cardiovascular screening of athletes. Hellenic J Cardiol. 2010;51(6):530–537.
  • Deligiannis AP, Kouidi EJ, Koutlianos NA, et al. Eighteen years' experience applying old and current strategies in the pre-participation cardiovascular screening of athletes. Hellenic J Cardiol. 2014;55(1):32–41.
  • Maron BJ, Zipes DP, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e256–e261.
  • Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2020; 0:1–80.
  • Steinvil A, Chundadze T, Zeltser D, et al. Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol. 2011;57(11):1291–1296.
  • Mosterd A. Pre-participation screening of asymptomatic athletes: "Don't do stupid stuff". Neth Heart J. 2018;26(3):123–126.
  • Benton NG, Maginot KR. Sudden cardiac death in young athletes: trying to find the needle in the haystack. Wisconsin Med J. 2007; 106:335–342.
  • Lobo SW, Pant S, Kharoshah MA, et al. Can rhabdomyolysis be a cause of sudden death in young athletes? Med Hypotheses. 2011;77(5):935–936.
  • Samaras T, Karavasiliadou S, Kouidi E, et al. Transtelephonic electrocardiographic transmission in the preparticipation screening of athletes. Int J Telemed Appl. 2008;2008:217909–4. vol
  • Assanelli D, Ermolao A, Carre F, et al. Standardized pre-competitive screening of athletes in some European and African countries: the SMILE study. Intern Emerg Med. 2014;9(6):709–434.
  • Ljungqvist A, Jenoure P, Engebretsen L, et al. The international olympic committee (IOC) consensus statement on periodic health evaluation of elite athletes March 2009. Br J Sports Med. 2009;43(9):631–643.
  • Johri AM, Poirier P, Dorian P, et al. Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position statement on the cardiovascular screening of competitive athletes. Can J Cardiol. 2019;35(1):1–11.
  • Maron BJ, Friedman RA, Kligfield P, et al. Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. Circulation. 2014;130(15):1303–1334.
  • Wexler R, Estes M. III. No: there is not enough evidence to support including ECG in the preparticipation sports evaluation. Am Fam Physician. 2015;92:343–344.
  • Corrado D, Pelliccia A, Heidbuchel H, et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J. 2010;31(2):243–259.
  • Drezner JA, Ackerman MJ, Anderson J, et al. Electrocardiographic interpretation in athletes: the 'Seattle criteria'. Br J Sports Med. 2013;47(3):122–124.
  • Drezner JA, Sharma S, Baggish A, et al. International criteria for electrocardiographic interpretation in athletes: consensus statement. Br J Sports Med. 2017;51(9):704–731.
  • Wheeler MT, Heidenreich PA, Froelicher VF, et al. Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes . Ann Intern Med. 2010;152(5):276–286.
  • Maron BJ, Estes NA, III, Maron MS. Is it fair to screen only competitive athletes for sudden death risk, or is it time to level the playing field? Am J Cardiol. 2018;121(8):1008–1010.
  • Lucas C, Kerkhof D, Jacilyn B, et al. The use of echocardiograms in preparticipation examinations. Curr Sports Med Rep. 2017;16:77–83.
  • Grazioli G, Merino B, Montserrat S, et al. Usefulness of echocardiography in preparticipation screening of competitive athletes. Rev Esp Cardiol. 2014;67(9):701–705.
  • La Gerche A, Baggish L, Knuuti J, et al. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death. JACC Cardiovasc Imaging. 2013;6(9):993–1007.
  • Borjesson M, Dellborg M, Niebauer J, et al. Recommendations for participation in leisure time or competitive sports in athletes-patients with coronary artery disease: a position statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2019;40(1):13–18.
  • Thompson PD, Myerburg RJ, Levine BD, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 8: coronary artery disease: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66(21):2406–2411.
  • Basavarajaiah S, Wilson M, Junagde S, et al. Physiological left ventricular hypertrophy or hypertrophic cardiomyopathy in an elite adolescent athlete: role of detraining in resolving the clinical dilemma. Br J Sports Med. 2006;40(8):727–729.
  • Vessella T, Cardillo R, Bianco M, et al. Marked negative T waves in athletes: ECG normalization after detraining. J Sports Med Phys Fitness. 2013; 53:520–523.
  • Basavarajaiah S, Boraita A, Whyte G, et al. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;51(23):2256–2262.
  • Riding NR, Sharma S, McClean G, et al. Impact of geographical origin upon the electrical and structural manifestations of the black athlete’s heart. Eur Heart J. 2019;40(1):50–58.
  • Saberi S, Day SM. Exercise and hypertrophic cardiomyopathy: Time for a change of heart. Circulation. 2018;137(5):419–421.
  • Klempfner R, Kamerman T, Schwammenthal E, et al. Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation center. Eur J Prev Cardiol. 2015;22(1):13–19.,.
  • Dias KA, Link MS, Levine BD. Exercise training for patients with hypertrophic cardiomyopathy: JACC review topic of the week. J Am Coll Cardiol. 2018;72(10):1157–1165.
  • Maron BJ, Semsarian C, Shen WK, et al. Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy. Heart Rhythm. 2009;6(5):599–602.
  • Matsuo K, Kurita T, Inagaki M, et al. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J. 1999;20(6):465–470.
  • Pelliccia A, Solberg EE, Papadakis M, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2019;40(1):19–33.
  • Maron BJ, Chaitman BR, Ackerman MJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109(22):2807–2816.
  • Schnell F, Behar N, Carré F. Long-QT syndrome and competitive sports. Arrhythm Electrophysiol Rev. 2018;7(3):187–192.
  • Fagard RH, Bjornstad H, Borjesson M, et al. ESC Study Group of Sports Cardiology recommendations for participation in leisure-time physical activities and competitive sports for patients with hypertension. Eur J Cardiovasc Prev Rehabil. 2005;12(4):326–331.
  • Kouidi E, Fahadidou-Tsiligiroglou A, Tassoulas E, et al. White-coat hypertension detected during screening of male adolescent athletes. Am J Hypertens. 1999;12(2 Pt 1):223–226.
  • Providencia R, Teixeira C, Segal O, et al. Empowerment of athletes with cardiac disorders: a new paradigm. Europace. 2018;20(8):1243–1251.
  • Ingles J, Zodgekar PR, Yeates L, et al. Guidelines for genetic testing of inherited cardiac disorders. Heart Lung Circ. 2011;20(11):681–687.
  • Richard P, Denjoy I, Fressart V, et al. Advising a cardiac disease gene positive yet phenotype negative or borderline abnormal athlete: is sporting disqualification really necessary? Br J Sports Med. 2012;46(Suppl 1):i59–i68.
  • Tan HL, Hofman N, van Langen IM, et al. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation. 2005;112(2):207–213.
  • Charron P, Arad M, Arbustini E, et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J. 2010;31(22):2715–2726.
  • Cerrone M, Priori SG. Genetics of sudden death: focus on inherited channelopathies. Eur Heart J. 2011;32(17):2109–2118.
  • Marian AJ. Hypertrophic cardiomyopathy: from genetics to treatment. Eur J Clin Invest. 2010;40(4):360–369.
  • Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103(1):89–95.
  • Fressart V, Duthoit G, Donal E, et al. Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace. 2010;12(6):861–868.,
  • Maron BJ, Spirito P, Shen WK, et al. Implantable cardioverter defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007;298(4):405–412.
  • Olshansky B, Atteya G, Cannom D, et al. Competitive athletes with implantable cardioverter-defibrillators-How to program? Data from the Implantable Cardioverter-Defibrillator Sports Registry. Heart Rhythm. 2019;16(4):581–587.
  • Heidbuchel H, Willems R, Jordaens L, et al. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: results from the European cohort. Eur J Prev Cardiolog. 2019;26(7):764–775.
  • Saarel EV, Law I, Berul CI, et al. Safety of sports for young patients with implantable cardioverter-defibrillators: long-term results of the Multinational ICD Sports Registry. Circ Arrhythm Electrophysiol. 2018;11(11):e006305.
  • Wang W, Orgeron G, Tichnell C, et al. Impact of exercise restriction on arrhythmic risk among patients with arrhythmogenic right ventricular cardiomyopathy. J Am Heart Ass. 2018;7:e008843.
  • WADA: anti-doping charter of athlete rights-draft-16 May 2019. https://www.wada-ama.org/en/resources/anti-doping-community/anti-doping-charter-of-athlete-rights-draft-16-may-2019
  • Dvorak J, Kirkendall D, Vouillamoz M. Therapeutic use exemption. Br J Sports Med. 2006; 40(Supplement 1):i40–i42.
  • La Gerche A, Brosnan M. Cardiovascular effects of performance-enhancing drugs. Circulation. 2017;135(1):89–99.
  • Deligiannis A, Björnstad H, Carre F, et al. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehabil. 2006;13(5):687–694.
  • Hernández-Guerra AI, Tapia J, Menéndez-Quintanal LM, et al. Sudden cardiac death in anabolic androgenic steroids abuse: case report and literature review. Forensic Sci Res. 2019;4(3):267–273.
  • Siebert D, Rao A. The use and abuse of human growth hormone in sports. Sports Health. 2018;10(5):419–426.
  • Reece AS, Norman A, Hulse GK. Acceleration of cardiovascular-biological age by amphetamine exposure is a power function of chronological age. Heart Asia. 2017;9(1):30–38.
  • Khan R, Osman M, Zafar S, et al. Energy drink induced ventricular fibrillation and cardiac arrest: a successful outcome. J Med Cases. 2015;6(9):409–412.
  • Inayat F, Majeed CN, Ali NS, et al. The risky side of weight-loss dietary supplements: disrupting arrhythmias causing sudden cardiac arrest. BMJ Case Rep. 2018;11(1):e227531.
  • Maron BJ. The paradox of exercise. N Engl J Med. 2000;343(19):1409–1411.
  • Merghani A, Malhotra A, Sharma S. The U-shaped relationship between exercise and cardiac morbidity. Trends Cardiovasc Med. 2016;26(3):232–240.
  • Teramoto M, Bungum TJ. Mortality and longevity of elite athletes. J Sci Med Sport. 2010;13(4):410–416.
  • Takeuchi T, Kitamura Y, Sado J, et al. Mortality of Japanese Olympic athletes: 1952-2017 cohort study. BMJ Open Sport Exerc Med. 2019;5(1):e000653
  • Alexiou S, Kouidi E, Fahadidou-Tsiligiroglou A, et al. Cardiac function after exhaustive open-sea swimming. J Sports Med Phys Fitness. 2005;45(1):98–104.
  • Eijsvogels TMH, Fernandez AB, Thompson PD. Are there deleterious cardiac effects of acute and chronic endurance exercise? Physiol Rev. 2016;96(1):99–125.
  • Tahir E, Scherz B, Starekova J, et al. Acute impact of an endurance race on cardiac function and biomarkers of myocardial injury in triathletes with and without myocardial fibrosis. Eur J Prev Cardiolog. 2020;27(1):94–104.
  • Vezzoli A, Dellanoce C, Mrakic-Sposta S, et al. Oxidative stress assessment in response to ultra-endurance exercise: Thiols Redox status and ROS production according to duration of a competitive race. Oxid Med Cell Longev. 2016;2016:1–13.
  • La Gerche A, Claessen G, Dymarkowski S, et al. Exercise-induced right ventricular dysfunction is associated with ventricular arrhythmias in endurance athletes. Eur Heart J. 2015;36(30):1998–2010.
  • Baker P, Leckie T, Harrington D, et al. Exercise-induced cardiac troponin elevation: an update on the evidence, mechanism and implications. Int J Cardiol Heart Vasc. 2019;22:181–186.
  • Mittleman MA, Maclure M, Tofler GH, et al. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of myocardial infarction onset study investigators. N Engl J Med. 1993;329(23):1677–1683.
  • Corrado D, Basso C, Poletti A, et al. Sudden death in the young. Is acute coronary thrombosis the major precipitating factor? Circulation. 1994;90(5):2315–2323.,.
  • Christou G, Pagourelias E, Anifanti M, et al. Exploring the determinants of the cardiac changes after ultra-long duration exercise: the echocardiographic Spartathlon study. Eur J Prev Cardiolog. 2020; 27(14):1467–1477.
  • Heidbüchel H, La Gerche A. The right heart in athletes. Evidence for exercise-induced arrhythmogenic right ventricular cardiomyopathy. Herzschrittmacherther Elektrophysiol. 2012;23(2):82–86.
  • Möhlenkamp S, Lehmann N, Breuckmann F, et al. Running: the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J. 2008;29(15):1903–1910.
  • Wilson M, O'Hanlon R, Prasad S, et al. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol. 2011;110(6):1622–1626.
  • Lechner K, Spanier B, Lechner B, et al. Your athlete-patient has a high coronary artery calcification score-‘Heart of Stone’. What should you advise? Is exercise safe? Br J Sports Med. 2020;0:1–2. DOI:https://doi.org/10.1136/bjsports-2019-100769
  • Mont L, Sambola A, Brugada J, et al. Long-lasting sport practice and lone atrial fibrillation. Eur Heart J. 2002;23(6):477–482.
  • Pelliccia A, Fagard R, Bjørnstad H, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2005;26(14):1422–1445.
  • Franklin B, Thompson P, Al-Zaiti S, et al. Exercise-related acute cardiovascular events and potential deleterious adaptations following long-term exercise training: placing the risks into perspective-an update: a scientific statement from the American Heart Association. Circulation. 2020;141(13):e705–e736.
  • Kumar K, Mandleywala S, Gannon M, et al. Development of a chest wall protector effective in preventing sudden cardiac death by chest wall impact (Commotio Cordis). Clin J Sport Med. 2017;27(1):26–30.
  • Hart L. Marathon-related cardiac arrest. Clin J Sport Med. 2013;23(5):409–410.
  • Tunstall Pedoe DS. Marathon cardiac deaths: the London experience. Sports Med. 2007;37(4-5):448–450.
  • Webner D, DuPrey KM, Drezner JA, et al. Sudden cardiac arrest and death in United States marathons. Med Sci Sports Exerc. 2012;44(10):1843–1845.
  • Thompson PD, Funk EJ, Carleton RA, et al. Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA 1982;247(18):2535–2538.
  • Chandra N, Bastiaenen R, Papadakis M, et al. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol. 2013;61(10):1027–1040.
  • Pelliccia A, Adami PE, Quattrini F, et al. Are Olympic athletes free from cardiovascular diseases? Systematic investigation in 2352 participants from Athens 2004 to Sochi 2014. Br J Sports Med. 2017;51(4):238–243.
  • Eijsvogels T, Thompson P, Franklin B. The “extreme exercise hypothesis”: Recent findings and cardiovascular health implications. Curr Treat Options Cardiovasc Med. 2018; 20(10):84–89.
  • Merghani A, Maestrini V, Rosmini S, et al. Prevalence of subclinical coronary artery disease in masters endurance athletes with a low atherosclerotic risk profile. Circulation. 2017;136(2):126–137.
  • D’Agostino R, Vasan R, Pencina M, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–753.
  • Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–2381.
  • Piepoli M, Abreu A, Albus C, et al. Update on cardiovascular prevention in clinical practice: a position paper of the European Association of Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol. 2020;27(2):181–205.
  • D’Ascenzi F, Caselli S, Alvino F, et al. Cardiovascular risk profile in Olympic athletes: an unexpected and underestimated risk scenario. Br J Sports Med. 2019;53(1):37–42.
  • O'Riordan CN, Newell M, Flaherty G. Cardiovascular disease risk factor profile of male Gaelic Athletic Association sports referees. Ir J Med Sci. 2018;187(4):915–924.
  • Siebert DM, Drezner JA. Sudden cardiac arrest on the field of play: turning tragedy into a survivable event. Neth Heart J. 2018;26(3):115–119.
  • Malhotra A, Dhutia H, Gati S, et al. Emergency response facilities including primary and secondary prevention strategies across 79 professional football clubs in England. Br J Sports Med. 2019;53(13):813–817.
  • Placing AEDs: where and how many. American Heart Association Web site. 2015. http://www.quickmedical.com/downloads/pdf/zoll/placing_aeds.pdf.
  • Borjesson M, Serratosa L, Carre F, et al. Consensus document regarding cardiovascular safety at sports arenas: position stand from the European Association of Cardiovascular Prevention and Rehabilitation (EACPR), section of Sports Cardiology. Eur Heart J. 2011;32(17):2119–2124.
  • Drezner J, Toresdahl B, Rao A, et al. Outcomes from sudden cardiac arrest in US high schools: a 2-year prospective study from the National Registry for AED use in sports. Br J Sports Med. 2013;47(18):1179–1183.
  • Aschieri D, Penela D, Pelizzoni V, et al. Outcomes after sudden cardiac arrest in sports centres with and without on-site external defibrillators. Heart. 2018;104(16):1344–1349.
  • Basso C, Rizzo S, Carturan E, et al. Cardiac arrest at rest and during sport activity: causes and prevention. Eur Heart J. 2020;22(Supplement_E):E20–E24.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.